Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients

Cited by (230)

Items 101–200 of 230

1. Physical deconditioning is the common denominator in both obese and overweight subjects with nonalcoholic steatohepatitis
   Curtis Kent Argo, Jonathan G. Stine, Zachary H. Henry, Carolin Lackner, James T. Patrie, ARTHUR L. WELTMAN, Stephen Hugh Caldwell · 2018 · Alimentary Pharmacology & Therapeutics
2. Non-invasive predictors of prognosis of Asian patients with histopathologically-confirmed lean nonalcoholic fatty liver disease
   Soichi Iritani, Norio Akuta, Yusuke Kawamura, Akira Kajiwara, Kayoko Kasuya, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi et al. · 2020 · BMC Gastroenterology
3. Anacardic acid mitigates liver fat accumulation and impaired glucose tolerance in mice fed a high‐fat and high‐sucrose diet
   Sangwon Chung, Eun Ju Shin, Hyo‐Kyoung Choi, Jae Ho Park, Jin‐Taek Hwang · 2020 · Food Science & Nutrition
4. Risk factors of nonalcoholic fatty liver disease in lean body mass population: A systematic review and meta‐analysis
   Shahinul Alam, Mohammed Eslam, SKM Nazmul Hasan, Kamrul Anam, Muhammad Abdul Baker Chowdhury, Md. Abdullah Saeed Khan, Mohammad Jahid Hasan, Rosmawati Binti Mohamed · 2021 · JGH Open
5. Low HDL cholesterol levels in women and hypertriglyceridemia in men: predictors of MASLD onset in individuals without steatosis
   Tsubasa Tsutsumi, Takumi Kawaguchi, Hideki Fujii, Yoshihiro Kamada, Yuichiro Suzuki, Koji Sawada, Miwa Tatsuta, Tatsuji Maeshiro, Hiroshi Tobita, Takemi Akahane et al. · 2025 · Journal of Gastroenterology
6. Association between serum uric acid-to-creatinine ratio and non-alcoholic fatty liver disease: a cross-sectional study in Chinese non-obese people with a normal range of low-density lipoprotein cholesterol
   Xiaoyu Wang, Yong Yun Han, Yufei Liu, Haofei Hu · 2022 · BMC Gastroenterology
7. Clinical Classification of Obesity and Implications for Metabolic Dysfunction-Associated Fatty Liver Disease and Treatment
   Yuping Ding, Quanjun Deng, Mei Yang, Haiyan Niu, Zuoyu Wang, Shihai Xia · 2023 · Diabetes Metabolic Syndrome and Obesity
8. Associations between fatty acid composition in serum cholesteryl esters and liver fat, basal fat oxidation, and resting energy expenditure: a population-based study
   Michael Fridén, Fredrik Rosqvist, Joel Kullberg, Håkan K. Ahlström, Lars Lind, Ulf Risérus · 2021 · American Journal of Clinical Nutrition
9. Metabolomics to identify fingerprints of carotid atherosclerosis in nonobese metabolic dysfunction-associated fatty liver disease
   Congxiang Shao, Lishu Xu, Pingguang Lei, Wei Wang, Shi‐Ting Feng, Junzhao Ye, Bihui Zhong · 2023 · Journal of Translational Medicine
10. The Beneficial Additive Effect of Silymarin in Metformin Therapy of Liver Steatosis in a Pre-Diabetic Model
    Martina Hüttl, Irena Marková, Denisa Miklánková, Iveta Zapletalová, Martin Poruba, Zuzana Rácová, Rostislav Večeřa, Hana Malínská · 2021 · Pharmaceutics
11. Metabolic dysfunction-associated steatotic liver disease, metabolic alcohol-related liver disease, and incident dementia: a nationwide cohort study
    Woo-Young Shin, Eun Seok Kang, Yun Hwan Oh, Meng Sha, Qiang Xia, Seogsong Jeong, Yoosun Cho · 2025 · BMC Gastroenterology
12. Waist-to-Hip Ratio and Inflammatory Parameters Are Associated with Risk of Non-Alcoholic Fatty Liver Disease in Patients with Morbid Obesity
    Marta Borges‐Canha, João Sérgio Neves, MARIA TAISSA DA SILVA, Fernando Miguel Mendonça, Telma Moreno, Sara Ribeiro, João Correa, Catarina Vale, Juliana Gonçalves, Helena Urbano Ferreira et al. · 2022 · Biomedicines
13. Associations of Sugar-Sweetened Beverages, Artificially Sweetened Beverages, and Pure Fruit Juice With Nonalcoholic Fatty Liver Disease: Cross-sectional and Longitudinal Study
    Ying Sun, Bowei Yu, Yuying Wang, Bin Wang, Xiao Tan, Yingli Lu, Kun Zhang, Ningjian Wang · 2023 · Endocrine Practice
14. The risk of cardiometabolic disorders in lean non-alcoholic fatty liver disease: A longitudinal study
    Ehimen C. Aneni, Márcio Sommer Bittencourt, Catherine Teng, Miguel Cainzos‐Achirica, Chukwuemeka U Osondu, Ahmed Soliman, Mouaz Husayn Al-Mallah, Matthew J Buddoff, Edison Roberto Parise, Raul Dias Santos et al. · 2020 · American Journal of Preventive Cardiology
15. Extrahepatic malignancies in metabolic dysfunction‐associated fatty liver disease: A nationwide cohort study
    Min Kyung Park, Moon Haeng Hur, Hye‐Sung Moon, Hyun‐Jae Shin, Sung Won Chung, Sungho Won, Yun Bin Lee, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu et al. · 2024 · Liver International
16. History of Gestational Diabetes and Incident Nonalcoholic Fatty Liver Disease: The Kangbuk Samsung Health Study
    Yoosun Cho, Yoosoo Chang, Seungho Ryu, Chanmin Kim, Sarah H. Wild, Christopher D. Byrne · 2023 · The American Journal of Gastroenterology
17. Comparing effects of beetroot juice and Mediterranean diet on liver enzymes and sonographic appearance in patients with non-alcoholic fatty liver disease: a randomized control trials
    Fateh, Hawal Lateef, Rashid, Sameeah Abdulrahman, Muhammad, Sarmad S., Al-Jaf, Sabah H., Ali, Ayad M. · 2023 · Frontiers in Nutrition
18. The metabolic profiles and body composition of non-obese metabolic associated fatty liver disease
    Yujuan Zhang, Liu-lan Xiang, Fang Qi, Yu-tian Cao, Wenhui Zhang, Tian-su Lv, Xiqiao Zhou · 2024 · Frontiers in Endocrinology
19. Comparison of clinical and metabolic profiles of lean versus non-lean nonalcoholic fatty liver disease
    Ann Margaret C. Navarroza, Stephen N. Wong · 2021 · Indian Journal of Gastroenterology
20. Mediators of dietary diversity score (DDS) on NAFLD in Iranian adults: a structural equation modeling study
    Azam Doustmohammadian, Bahareh Amirkalali, Esmaeel Gholizadeh, Mahmoodreza Khoonsari, Amir Hossein Faraji, Mehdi Nikkhah, Mansooreh Maadi, Nima Motamed, Mohsen Reza Mansourian, Melika Hajjar et al. · 2022 · European Journal of Clinical Nutrition
21. Weight loss breaks the bond between nonalcoholic fatty liver disease and cardiovascular diseases: A clinical and epidemiological perspective
    Moein Ala, Seyed Parsa Eftekhar · 2023 · Obesity Reviews
22. Relationship between dietary macronutrient composition and non-alcoholic fatty liver disease in lean and non-lean populations: a cross-sectional study
    Bahareh Amirkalali, Mahmoodreza Khoonsari, Masoudreza Sohrabi, Hossein Ajdarkosh, Nima Motamed, Mansooreh Maadi, Hossein Nobakht, Esmaeel Gholizadeh, Farhad Zamani · 2021 · Public Health Nutrition
23. Advances in our understanding of the molecular heterogeneity of fatty liver disease: toward informed treatment decision making
    Carlos Jose Pirola, Silvia C. Sookoian · 2023 · Expert Review of Gastroenterology & Hepatology
24. Lean non‐alcoholic fatty liver disease and associated metabolic disturbance: A Saudi Arabian cross‐sectional study
    Yasir Mohammed Khayyat · 2021 · Physiological Reports
25. Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease
    Ioanna Aggeletopoulou, Maria Kalafateli, Efthymios P. Tsounis, Christos K Triantos · 2023 · International Journal of Molecular Sciences
26. Central Obesity is an Independent Determinant of Advanced Fibrosis in Lean Patients With Nonalcoholic Fatty Liver Disease
    Arka De, Naveen Bhagat, Manu Mehta, Priya Singh, Sahaj Rathi, Nipun Verma, Sunil Taneja, Madhumita Premkumar, Ajay Kumar. Duseja · 2024 · Journal of Clinical and Experimental Hepatology
27. Lean MASLD and Cardiovascular Disease: A Review
    Nachum Lebovics, Gabriel Heering, William H. Frishman, Edward Lebovics · 2025 · Cardiology in Review
28. Beyond BMI: revealing metabolic risk in lean MASLD
    Adrian Rotaru, Ermina Stratina, Laura Huiban · 2025 · Archive of Clinical Cases
29. Self-reported snoring is associated with nonalcoholic fatty liver disease
    Hui Wang, Qian Gao, Simin He, Yanping Bao, Hongwei Sun, Lingxian Meng, Jie Liang, Chenming Sun, Shuohua Chen, Liying Cao et al. · 2020 · Scientific Reports
30. Discovery of JND003 as a New Selective Estrogen-Related Receptor α Agonist Alleviating Nonalcoholic Fatty Liver Disease and Insulin Resistance
    Liufeng Mao, Lijie Peng, Xiaomei Ren, Yi Chu, Tao Nie, Wanhua Lin, Andrew E. Libby, Yong Xu, Yu Chang, Chong Lei et al. · 2022 · ACS Bio & Med Chem Au
31. Clinical and Laboratory Characteristics of Normal Weight and Obese Individuals with Non-Alcoholic Fatty Liver Disease
    Anca Victorita Trifan, Adrian Rotaru, Remus Stafie, Ermina Stratina, Sebastian Zenovia, Robert Năstasă, Laura Huiban, Tudor Cuciureanu, Cristina Maria Muzica, Stefan Andrei Chiriac et al. · 2022 · Diagnostics
32. Association of non-alcoholic fatty liver disease with total testosterone in non-overweight/obese men with type 2 diabetes mellitus
    Lijuan Yang, Jingzong Zhou, Yanjun Zheng, Xiang Hu, Zhiying He, Lin-Jia Du, Xuejiang Gu, Xiaoying Huang, Yao Li, Y. Q. Li et al. · 2023 · Journal of Endocrinological Investigation
33. Triglyceride level and soft drink consumption predict nonalcoholic fatty liver disease in nonobese male adolescents
    Akira Kado, Yukiko Inoue, Kyoji Moriya, Takeya Tsutsumi, Kazuhiko Ikeuchi, Kazuya Okushin, Hiroshi Yotsuyanagi, Kazuhiko Koike, Mitsuhiro Fujishiro · 2023 · Hepatology Research
34. Association between non-alcoholic fatty liver disease and metabolically healthy deterioration across different body shape phenotypes at baseline and change patterns
    Lei Liu, Wang Changfa, Wang Jian-gang, Chen Zhiheng, Ting Yuan, Xiaoling Zhu, Deng Yuling, Wang Yaqin · 2022 · Scientific Reports
35. Silybin A from Silybum marianum reprograms lipid metabolism to induce a cell fate-dependent class switch from triglycerides to phospholipids
    Solveigh C. Koeberle, Maria Thürmer, Markus Werner, Julia Grander, Laura Hofer, André Gollowitzer, Fengting Su, Loc Le Xuan, Felix J. Benscheid, Ehsan Bonyadi Rad et al. · 2025 · Theranostics
36. Metabolic and Risk Profiles of Lean and Non-Lean Hepatic Steatosis among US Adults
    Meiling Li, Weiping Zhang, Xiude Li, Shaoxian Liang, Yaozong Zhang, Yufeng Mo, Songxian Rao, Honghua Zhang, Yong Chun Huang, Yu Zhu et al. · 2023 · Nutrients
37. Pleiotropy within gene variants associated with nonalcoholic fatty liver disease and traits of the hematopoietic system
    Carlos Jose Pirola, Adrián Salatino, Silvia C. Sookoian · 2021 · World Journal of Gastroenterology
38. Prediction of Metabolic Dysfunction–Associated Steatotic Liver Disease via Advanced Machine Learning Among Chinese Han Population
    Na Wu, Mofan Feng, Hanhua Zhao, Shuang Wei, Xinyu Shi, Xinying Xiong, Wenjun Zhou, Shengfu You, Hualing Song, Huiting Yu et al. · 2025 · Obesity Surgery
39. Food Network Analysis in Non-Obese Patients with or without Steatosis
    Rossella Donghia, Pasqua Letizia Pesole, Sergio Coletta, Caterina Bonfiglio, Giovanni De Pergola, Sara De Nucci, Roberta Rinaldi, Gianluigi Giannelli · 2023 · Nutrients
40. Targeted metabolomics study of fatty-acid metabolism in lean metabolic-associated fatty liver disease patients
    Pei-Qi Sun, Wen-Min Dong, Yi-Fu Yuan, Qin Cao, Xiaoyan Chen, Lili Guo, Yuanye Jiang · 2024 · World Journal of Gastroenterology
41. Clinical characteristics of lean and non-lean non-alcoholic fatty liver disease: a cross-sectional study
    Min Xu, Rui Gong, Jiao Xie, Sanping Xu, Shi Wang · 2025 · Nutrition & Metabolism
42. Long-chain polyunsaturated fatty acids and extensively hydrolyzed casein-induced browning in a Ucp-1 reporter mouse model of obesity
    Liufeng Mao, Jiwen Lei, Marieke H. Schoemaker, Bingxiu Ma, Yan Zhong, Tim T. Lambers, Eric A.F. van Tol, Yulai Zhou, Tao Nie, Donghai Wu · 2018 · Food & Function
43. Association between Nonalcoholic Fatty Liver and Gensini Score in Patients with Coronary Heart Disease: A Cross-Sectional Study
    Ping Wang, Hua Qiang, Yan Song, Ying Dang, Hui Luan, Lifei Cao, Qing Cui, Gang Tian · 2019 · Cardiology
44. Nonobese nonalcoholic fatty liver disease
    Elizabeth S. Aby, Sammy Saab · 2017 · Clinical Liver Disease
45. Nonalcoholic fatty liver disease in lean subjects: is it all metabolic-associated fatty liver disease?
    Mariana Verdelho Machado · 2020 · Hepatoma Research
46. Noninvasive Risk Stratification for Nonalcoholic Fatty Liver Disease Among Living Liver Donor Candidates: A Proposed Algorithm
    Nilay Danış, Sharon R. Weeks, Ahyoung Kim, Azarakhsh Baghdadi, Maryam Ghadimi, Ihab R. Kamel, Behnam Saberi, Tinsay A. Woreta, Jacqueline Garonzik‐Wang, Benjamin Philosophe et al. · 2021 · Liver Transplantation
47. Editorial: lean and obese NAFLD —similar siblings
    Thomas E. Mellor, Dawn McDowell Torres · 2017 · Alimentary Pharmacology & Therapeutics
48. Non-alcoholic fatty liver disease: beyond the liver is an emerging multifaceted systemic disease
    Luigi Elio Adinolfi, Aldo Marrone, Luca Rinaldi · 2018 · HepatoBiliary Surgery and Nutrition
49. Evaluation of risk factors for non-alcoholic fatty liver disease in India: A systematic review and meta-analysis
    Suthanthira Kannan, Maria Nelliyanil, Roopa R Mendagudli, Swetha Rajeshwari, Chandralekha Kona, Rashmi Kundapur, Shreyaswi M Sathyanath, Vaman Kulkarni, Sumit Suresh Aggarwal · 2023 · Journal of Education and Health Promotion
50. Liver stiffness measurements in patients with metabolic dysfunction-associated steatotic liver disease: Updates on the method effectiveness and perspectives
    Olga A. Sukocheva, Tsai‐Wing Ow, Damian Harding, Marc Le Mire, Edmund Tse · 2025 · World Journal of Hepatology
51. Early cardiac electrical and structural changes in patients with non-obese non-alcoholic fatty liver disease
    Ekrem Aksu, Abdullah Sökmen, Murat İspiroğlu, Kadir Gişi, Enes Celik, Ahmet Çağrı Aykan · 2021 · Kardiologiia
52. Clinical Differences and Non-Alcoholic Fatty Liver Disease-Related Factors of Lean and Non-Lean Patients with Metabolic Syndrome
    Punyisa Boonchai, Chayanis Kositamongkol, Suchanart Jitrukthai, Sukumal Phothirat, Euarat Mepramoon, Pongpol Nimitpunya, Weerachai Srivanichakorn, Thanet Chaisathaphol, Chaiwat Washirasaksiri, Chonticha Auesomwang et al. · 2022 · Journal of Clinical Medicine
53. Identification of clinical phenotypes associated with poor prognosis in patients with nonalcoholic fatty liver disease via unsupervised machine learning
    Takanori Ito, Hikaru Morooka, Hirokazu Takahashi, Hideki Fujii, Michihiro Iwaki, Hideki Hayashi, Hidenori Toyoda, Satoshi Oeda, Hideyuki Hyogo, Miwa Kawanaka et al. · 2023 · Journal of Gastroenterology and Hepatology
54. Emerging role of nanotechnology in treatment of non-alcoholic fatty liver disease (NAFLD)
    Atie Moghtadaie, Hamidreza Mahboobi, Somayeh Fatemizadeh, Mohammad Amjad Kamal · 2023 · EXCLI journal
55. Associations between body composition profile and hypertension in different fatty liver phenotypes
    Xiaoyin Huang, Yuchen Zeng, Mingyang Ma, Liangguang Xiang, Qingdan Liu, Ling Xiao, Ruimei Feng, Wanxin Li, Xiaoling Zhang, Moufeng Lin et al. · 2023 · Frontiers in Endocrinology
56. Torso Shape Improves the Prediction of Body Fat Magnitude and Distribution
    Simon B Choppin, Alice May Bullas, Michael Thelwell · 2022 · International Journal of Environmental Research and Public Health
57. DEXA Scan Body Fat Mass Distribution in Obese and Non-Obese Individuals and Risk of NAFLD—Analysis of 10,865 Individuals
    Caitlyn Tan, Kai En Chan, Cheng Han Ng, Michael Tseng, Nicholas L. X. Syn, Ansel Shao Pin Tang, Yip Han Chin, Wen Hui Lim, Darren Jun Hao Tan, Nicholas Chew et al. · 2022 · Journal of Clinical Medicine
58. Increased risk of cardiometabolic disease in normal-weight individuals with non-alcoholic fatty liver disease
    Myong-Won Seo, Youngseob Eum, Hyun Chul Jung · 2023 · Obesity Research & Clinical Practice
59. Non-obese non-alcoholic fatty liver disease and the risk of chronic kidney disease: a systematic review and meta-analysis
    Yixian You, Pei Xiong, Wei Jiang, Qingmin Zeng, Lang Bai, Taoyou Zhou, Xiaoju Lv, Hong Tang, Dongbo Wu · 2024 · PeerJ
60. Heterogeneity of cardiometabolic and hepatic fibrosis risks in nonalcoholic fatty liver disease among lean, overweight, and obese populations: a multicenter cross-sectional study
    Lili Gao, Wujun Xiong, Ying Wang, Wei Wang, Xiaoliang Wang, Hao Zhang · 2025 · European Journal of Gastroenterology & Hepatology
61. Amendment “New nomenclature for MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)” to the S2k guideline “Non-alcoholic fatty liver disease” (v.2.0/April 2022) of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS)
    Authors, Collaborators · 2024 · Zeitschrift für Gastroenterologie
62. I148M variant of PNPLA3-gene is not associated with metabolic syndrome in patients with NAFLD in the Indian ethnicity
    Govardhan Bale, Mitnala Sasikala, Nagaraja Rao Padaki, Mithun Sharma, Anand V. Kulkarni, Smita C. Pawar, Nageshwar Reddy D, Ravikanth Vishnubhotla · 2022 · Human Gene
63. Potencial efecto terapéutico de los polifenoles obtenidos de la cáscara de granada en la esteatosis hepática
    Andrés Bustamante, Diego F. García‐Díaz, Paula Jiménez, Rodrigo B. Valenzuela, María Elsa Pando, Francisca Echeverría · 2022 · Revista chilena de nutrición
64. Clinical Factors Associated with Non-Obese Nonalcoholic Fatty Liver Disease Detected among US Adults in the NHANES 2017–2018
    Zayd Adnan Razouki, Xiaotao Zhang, Jessica Park Hwang, Natalia I. Heredia · 2022 · Journal of Clinical Medicine
65. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: pathophysiology and implications for cardiovascular disease
    Nicholas Chew, Mark Dhinesh Muthiah, Arun Jayant Sanyal · 2023 · Elsevier eBooks
66. Non-alcoholic fatty liver disease in patients with inflammatory bowel disease might boost cardiovascular disease burden
    Dimitrios Patoulias · 2019 · Archives of Medical Science - Atherosclerotic Diseases
67. Development trends in medical science and practice: the experience of countries of Eastern Europe and prospects of Ukraine
    Liliya V. Batyuk, Nataliya Kizilova · 2018 · Izdevniecība “Baltija Publishing” eBooks
68. Letter: Helicobacter pylori in lean and obese patients with non‐alcoholic fatty liver disease
    Jannis Kountouras, Stergios A. Pοlyzos, Panagiotis Katsinelos, Michael Doulberis, Christos Zavos, Evangelos I. Kazakos, Marina Kleopatra Boziki, Dimitri Tzivras, Georgios Kotronis · 2017 · Alimentary Pharmacology & Therapeutics
69. Non-alcoholic fatty liver disease in people with normal body weight
    Светлана Владимировна Туркина, Тыщенко Ирина Андреевна, М. Н. Титаренко · 2024 · Экспериментальная и клиническая гастроэнтерология
70. Association of Non-alcoholic Fatty Liver Disease with Body Fat Percentage in Normal-Weight Individuals
    Zeynab Hatamizargaran, Mohammadreza Sasani, Masoumeh Akhlaghi · 2021 · Shiraz E-Medical Journal
71. Familial clustering of nonalcoholic fatty liver disease in first‐degree relatives of adults with lean nonalcoholic fatty liver disease
    Sorachat Niltwat, Chanin Limwongse, Natthinee Charatcharoenwitthaya, Duangkamon Bunditvorapoom, Wimolrak Bandidniyamanon, Phunchai Charatcharoenwitthaya · 2023 · Liver International
72. Cardiometabolic and Metabolic Profiles of Lean/Normal, Overweight and Obese Patients with Nonalcoholic Fatty Liver Disease
    Siyao Wang, Yong Zhang, Xiaoya Qi, Xiaoyang Xu · 2024 · Diabetes Metabolic Syndrome and Obesity
73. Association of Low Skeletal Muscle Mass with the Phenotype of Lean Non-Alcoholic Fatty Liver Disease
    Jun Hyeon Byeon, Min Kyu Kang, Min-Cheol Kim · 2022 · Healthcare
74. Markers Of Insulin Resistance and Their Clinical Implications In Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease
    Oana Albai, Adina Braha, Romulus Zorin Timar, Sandra Lazăr, Simona Daniela Popescu, Bogdan Timar · 2026 · Diabetes Metabolic Syndrome and Obesity
75. The role of primary care in response to the global liver disease syndemic: a Lancet Gastroenterology & Hepatology Commission
    Helen Jarvis, Paul Brennan, Teresa Casanovas, Kelly Casler, Monica Desai, Philip H Evans, John Francis Dillon, Ignazio Grattagliano, Kate Hallsworth, Vanessa Hebditch et al. · 2026 · The Lancet. Gastroenterology & hepatology
76. Phospholipid metabolism-related genotypes of PLA2R1 and CERS4 contribute to nonobese MASLD
    Congxiang Shao, Junzhao Ye, Zhi Dong, Bing Liao, Shi‐Ting Feng, Shixian Hu, Bihui Zhong · 2024 · Hepatology Communications
77. Garcinia brasiliensis Leaves Extracts Inhibit the Development of Ascitic and Solid Ehrlich Tumors
    L.S. Silva, Eduardo Cavallini, Rafael André da Silva, Monielle Sant’Ana, Ariane Harumi Yoshikawa, Thiago Salomão, Bianca Huang, Paula Craice, Luiz Philipe de Souza Ferreira, Heitor Pedro Della Matta et al. · 2024 · Pharmaceuticals
78. Prediabetic cardiomyopathy is attenuated by hypothalamic PVN oxytocin neuron activation
    Anna Nilsson, Joan B. Escobar, Kiralee Kuraoka, Ian Venter, Cielo A. Carnate, Matthew W. Kay, David Mendelowitz, Kathryn Jaques Schunke · 2025 · The Journal of Physiology
79. Serum Nesfatin-1 in Patients with Metabolic Associated Fatty Liver Disease
    2024 · The Egyptian Journal of Hospital Medicine
80. Nonalcoholic Fatty Liver Disease in Nonobese Subjects of African Origin Has Atypical Metabolic Characteristics
    Debbie S. Thompson, Ingrid A. Tennant, Deanne Soares, Clive Osmond, Christopher D. Byrne, Terrence Forrester, Michael S Boyne · 2019 · Journal of the Endocrine Society
81. Propylthiouracil Induced Rat Model Reflects Heterogeneity Observed in Clinically Non-Obese Subjects with Nonalcoholic Fatty Liver Disease
    Yu Jin, Qiuyan Liu, Yuqin Wang, Bing Wang, Jing An, Qimeng Chen, Tao Wang, Jing Shang · 2024 · International Journal of Molecular Sciences
82. Assessing metabolic-dysfunction associated steatotic liver disease in patients with obstructive sleep apnea: a cross-sectional study
    Mohammed Al-Houqani, Mohamed Hamad Alzaki, Adnan Agha · 2026 · Sleep And Breathing
83. Lifespan approaches for the prevention and management of steatotic liver disease
    Shira Zelber‐Sagi, Dana Ivancovsky-Wajcman, Carina Kugelmas, Ali A. Weinstein, Vincent Wai‐Sun Wong, Laurent Castéra, J. Bernadette Moore, Marialena Mouzaki, Kate Hallsworth, James M. Paik et al. · 2026 · Nature Reviews Gastroenterology & Hepatology
84. Global research trends of lean metabolic dysfunction-associated steatotic liver disease (lean MASLD) from 2005 to 2024: Bibliometric and visualization analysis
    Qi Yu, Mei Liu, Liyuan He, Feng Hua · 2026 · Medicine
85. THE INFLUENCE OF ENVIRONMENTAL FACTORS ON NONALCOHOLIC FATTY LIVER DISEASE AND OBESITY
    K. B. Kvit · 2018 · Izdevniecība “Baltija Publishing” eBooks
86. Effect modification of hepatitis B viral load on the association between metabolic risk factors and hepatic steatosis
    Michelle Y. Shi, Christopher Wong, Tai‐Ping Lee · 2022 · Translational Gastroenterology and Hepatology
87. Metabolic Profile of Non-Alcoholic Fatty Liver Disease in Non-Obese Patients
    Md. Shafiqul Islam, FM Monjur Hasan, Sumaia Jahan, Raihan Ahmad, Md. Ahsan Habib, Richmond Ronald Gomes · 2025 · International Journal of Clinical Endocrinology and Metabolism
88. Non-alcoholic Fatty Liver Disease in Non-obese Patients
    Christopher J. Schmoyer, Mohammad Shadab Siddiqui · 2017 · Current Hepatology Reports
89. Adult Non-alcoholic Fatty Liver Disease (NAFLD)
    Julie Steen Pedersen, Flemming Bendtsen · 2018 · Springer eBooks
90. Schlanke Patienten
    Roman Liebe, Marcin Jan Krawczyk · 2022 · Springer eBooks
91. Editorial: non‐alcoholic fatty liver disease—it is better to be slender after all
    Jonathan Chung‐Fai Leung, Vincent Wai‐Sun Wong · 2017 · Alimentary Pharmacology & Therapeutics
92. Editorial: hepatitis B, fatty liver and metabolic syndrome—Interaction or co‐existence? Authors’ reply
    Yuan‐Hung Kuo, Sheng‐Nan Lu · 2018 · Alimentary Pharmacology & Therapeutics
93. Effets cardio-métaboliques des glucides
    Chloé Amouyal, Héléna Mosbah, Fabrizio Andréelli · 2018 · Médecine des Maladies Métaboliques
94. Letter: the association between chronic viral hepatitis and metabolic syndrome – Authors' reply
    Yuan‐Hung Kuo, Sheng‐Nan Lu · 2018 · Alimentary Pharmacology & Therapeutics
95. Urinary PH as an Indicator of non-Alcoholic Fatty Liver Disease
    F.M. Khalil, M. El-Assal, Ahmed Mohamd Hussein Dabour, Amira Ahmed, W.A. Abdallah · 2020 · Benha Journal of Applied Sciences
96. Targeted therapeutic alternative splicing
    Sue Fletcher · 2014 · Murdoch University Research Portal
97. Differenzierung verschiedener Fettlebererkrankungen anhand laborchemischer und anamnestischer Parameter
    Bernd Rensing · 2021
98. Nonalcoholic Fatty Liver Disease in Lean Chinese: The Public Health Crisis We Can No Longer Ignore
    Peizhi Deng, Liang Weng, YaLan Li, Jie Wang, Fei Li, Zhiheng Chen, Jiangang Wang, Yiping Yang, Haibo Tang, LiYong Zhu et al. · 2022 · SSRN Electronic Journal
99. Diagnostik: Algorithmus und Leberbiopsie
    Elke Roeb · 2022 · Springer eBooks
100. Metabolic-associated fatty liver disease: pharmacological management
     Yiwen Shi, Jian‐Gao Fan · 2023 · Elsevier eBooks